Login / Signup

[The influence of the drug recognan (citicoline) on neurodynamic characteristics of mental activity in patients with mild cognitive impairment].

S A NemkovaD V SemenovNikolay N ZavadenkoM Yu Vozvyshaeva
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
The results obtained showed that the use of the drug recognan (citicoline) has a positive effect on the indicators of visual-motor coordination and spatial representations, neurodynamic characteristics of movement, and cognitive functions. After a 2-week treatment with recognan improved graphical sample, 84% of patients, with reliable improvement according to the Wilcoxon (p=0.0002), the sample in the compression of the fingers 60%, as well as coordination 60%, the accounting functions in 44%. After a month (30 day) treatment course recomanem there was an increase in indices of samples for the compression of fingers in 71.4% of patients, with significant improvement (p=0.0499) and run the graphical samples of 71.4%, coordination at 46.4%, counting functions - 48% patients.
Keyphrases
  • mild cognitive impairment
  • cognitive decline
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • working memory
  • randomized controlled trial
  • mental health
  • emergency department